SC 13G/A | 2024-02-14 | Redmile Group, LLC | Deciphera Pharmaceuticals, Inc. | 8,359,768 | 9.9% | EDGAR |
SC 13G/A | 2024-02-14 | BRAIDWELL LP | Deciphera Pharmaceuticals, Inc. | 2,385,623 | 2.9% | EDGAR |
SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | Deciphera Pharmaceuticals, Inc. | 5,200,000 | 6.5% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Deciphera Pharmaceuticals, Inc. | 4,401,636 | 5.5% | EDGAR |
SC 13G/A | 2024-02-12 | Flynn James E | Deciphera Pharmaceuticals, Inc. | 5,788,024 | 7.2% | EDGAR |
SC 13G/A | 2024-02-09 | Brightstar Associates LLC | Deciphera Pharmaceuticals, Inc. | 23,059,708 | 28.2% | EDGAR |
SC 13G/A | 2024-02-06 | GOLDMAN SACHS GROUP INC | Deciphera Pharmaceuticals, Inc. | 2,007,447 | 2.5% | EDGAR |
SC 13G/A | 2024-01-26 | BlackRock Inc. | Deciphera Pharmaceuticals, Inc. | 5,976,266 | 7.5% | EDGAR |
SC 13G/A | 2024-01-23 | STATE STREET CORP | Deciphera Pharmaceuticals, Inc. | - | 3.1% | EDGAR |
SC 13G | 2023-03-22 | Flynn James E | Deciphera Pharmaceuticals, Inc. | 4,627,310 | 6.1% | EDGAR |
SC 13G/A | 2023-02-14 | BANK OF AMERICA CORP /DE/ | Deciphera Pharmaceuticals, Inc. | 302,410 | 0.4% | EDGAR |
SC 13G/A | 2023-02-14 | Redmile Group, LLC | Deciphera Pharmaceuticals, Inc. | 7,108,097 | 9.9% | EDGAR |
SC 13G/A | 2023-02-14 | ARMISTICE CAPITAL, LLC | Deciphera Pharmaceuticals, Inc. | 5,172,000 | 7.6% | EDGAR |
SC 13G | 2023-02-14 | BRAIDWELL LP | Deciphera Pharmaceuticals, Inc. | 4,599,484 | 6.7% | EDGAR |
SC 13G/A | 2023-02-10 | Flynn James E | Deciphera Pharmaceuticals, Inc. | 2,349,228 | 3.5% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Deciphera Pharmaceuticals, Inc. | 4,745,321 | 7.0% | EDGAR |
SC 13G/A | 2023-02-08 | GOLDMAN SACHS GROUP INC | Deciphera Pharmaceuticals, Inc. | 3,836,159 | 5.7% | EDGAR |
SC 13G/A | 2023-02-08 | Brightstar Associates LLC | Deciphera Pharmaceuticals, Inc. | 23,107,844 | 28.2% | EDGAR |
SC 13G/A | 2023-02-03 | STATE STREET CORP | Deciphera Pharmaceuticals, Inc. | - | 5.1% | EDGAR |
SC 13G/A | 2023-02-03 | BlackRock Inc. | Deciphera Pharmaceuticals, Inc. | 5,420,025 | 8.0% | EDGAR |